Sucampo off 14% premarket on pending stock sales by shareholders

• Thinly-traded Sucampo Pharmaceuticals (NASDAQ:SCMP) is set for a gap down at the open in response to its disclosure that existing shareholders intend to sell shares in an upcoming public offering.
• Previously: Sucampo initiates equity offering by existing shareholders (March 25)